No Data
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $54
Omnicell Announces OmniSphere, A Next-Generation, Cloud Native, Software Workflow Engine And Data Platform
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Raises Target Price to $69
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?
LSPedia AND OMNICELL COLLABORATE IN AN EFFORT TO ADVANCE PHARMACY SUPPLY CHAIN COMPLIANCE AND INNOVATION FOR HOSPITALS AND HEALTH SYSTEMS
Den the Dragon :
